US Patent 7553815 Therapeutic use
Patent 7553815 was granted and assigned to The University of Manchester on June, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Nigel James Bundred0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+201 characters)
Article
Patent abstract
A method of chemoprevention of the onset of invasive breast cancer in a high risk patient comprises administering to the patient an effective amount of an EGFR tyrosine kinase inhibitor.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07553815 Therapeutic use US Patent 7553815 Therapeutic use
Infobox
Patent Number
07553815
Patent Number
7553815
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07553815 Therapeutic use
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07553815
Date of patent
June 30, 2009
Patent application number
10111390
Date Filed
November 1, 2000
Patent primary examiner
Find more entities like US Patent 7553815 Therapeutic use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.